This indicates that those endothelial alterations are not due to c-mpl deficiency-related changes in bone marrow hematopoietic cells and that, like for prevention of inflammation-induced bleeding [48], a very limited number of platelets is sufficient to maintain endothelial integrity in AT-3 tumors. This evidence concerns the gene MPL and hyperinsulinemic hypoglycemia, familial, 4.